Brilliant blue R dye is capable of suppressing amyloid fibril formation of lysozyme

References

• Agnati, L. F., Guidolin, D., Leo, G., Genedani, S., Arhem, P., Forni, A., … Fuxe, K. (2007). Role of cooperativity in protein folding and protein mosaic assemblage relevance for protein conformational diseases. Current Protein & Peptide Science, 8, 460–470.10.2174/138920307782411419
   PubMed Web of Science ®Google Scholar
• Arnaudov, L. N., & de Vries, R. (2005). Thermally induced fibrillar aggregation of hen egg white lysozyme. Biophysical Journal, 88, 515–526.10.1529/biophysj.104.048819
   PubMed Web of Science ®Google Scholar
• Brown, M. B., Miller, J. N., & Seare, N. J. (1995). An investigation of the use of nile-red as a long-wavelength fluorescent-probe for the study of alpha(1)-acid glycoprotein–drug interactions. Journal of Pharmaceutical and Biomedical Analysis, 13, 1011–1017.10.1016/0731-7085(95)01524-O
   PubMed Web of Science ®Google Scholar
• Cavaliere, P., Torrent, J., Prigent, S., Granata, V., Pauwels, K., Pastore, A., … Zagari, A. (2013). Binding of methylene blue to a surface cleft inhibits the oligomerization and fibrillization of prion protein. Biochimica et Biophysica Acta (BBA) – Molecular Basis of Disease, 1832, 20–28.10.1016/j.bbadis.2012.09.005
   PubMed Web of Science ®Google Scholar
• Chen, Y. H., Tseng, C. P., How, S. C., Lo, C. H., Chou, W. L., & Wang, S. S. (2016). Amyloid fibrillogenesis of lysozyme is suppressed by a food additive brilliant blue FCF. Colloids and Surfaces B: Biointerfaces, 142, 351–359.10.1016/j.colsurfb.2016.02.064
   PubMed Web of Science ®Google Scholar
• Cohen, F. E., & Kelly, J. W. (2003). Therapeutic approaches to protein-misfolding diseases. Nature, 426, 905–909.10.1038/nature02265
   PubMed Web of Science ®Google Scholar
• Cser, A., Nagy, K., & Biczok, L. (2002). Fluorescence lifetime of nile red as a probe for the hydrogen bonding strength with its microenvironment. Chemical Physics Letters, 360, 473–478.10.1016/S0009-2614(02)00784-4
   Web of Science ®Google Scholar
• Das, U., Hariprasad, G., Ethayathulla, A. S., Manral, P., Das, T. K., Pasha, S., … Srinivasan, A. (2007). Inhibition of protein aggregation: Supramolecular assemblies of arginine hold the key. PLoS ONE, 2, e1176.
   PubMed Web of Science ®Google Scholar
• Defelice, F. G., & Ferreira, S. T. (2002). Physiopathological modulators of amyloid aggregation and novel pharmacological approaches in Alzheimer’s disease. Anais Da Academia Brasileira De Ciencias, 74, 265–284.10.1590/S0001-37652002000200006
   PubMed Web of Science ®Google Scholar
• Dumoulin, M., Kumita, J. R., & Dobson, C. M. (2006). Normal and aberrant biological self-assembly: Insights from studies of human lysozyme and its amyloidogenic variants. Accounts of Chemical Research, 39, 603–610.10.1021/ar050070 g
   PubMed Web of Science ®Google Scholar
• Estrada, L. D., & Soto, C. (2007). Disrupting beta-amyloid aggregation for Alzheimer disease treatment. Current Topics in Medicinal Chemistry, 7, 115–126.10.2174/156802607779318262
   PubMed Web of Science ®Google Scholar
• Filosa, A., & English, A. M. (2001). Mass spectral analysis of protein-based radicals using DBNBS – Nonradical adduct formation vs. spin trapping. Journal of Biological Chemistry, 276, 21022–21027.10.1074/jbc.M100644200
   PubMed Web of Science ®Google Scholar
• Fraiji, L. K., Hayes, D. M., & Werner, T. C. (1992). Static and dynamic fluorescence quenching experiments for the physical chemistry laboratory. Journal of Chemical Education, 69, 424–428.10.1021/ed069p424
   Web of Science ®Google Scholar
• Frare, E., de Laureto, P. P., Zurdo, J., Dobson, C. M., & Fontana, A. (2004). A highly amyloidogenic region of hen lysozyme. Journal of Molecular Biology, 340, 1153–1165.10.1016/j.jmb.2004.05.056
   PubMed Web of Science ®Google Scholar
• Frare, E., Mossuto, M. F., de Laureto, P. P., Tolin, S., Menzer, L., Dumoulin, M., … Fontana, A. (2009). Characterization of oligomeric species on the aggregation pathway of human lysozyme. Journal of Molecular Biology, 387, 17–27.10.1016/j.jmb.2009.01.049
   PubMed Web of Science ®Google Scholar
• Gazova, Z., Bellova, A., Daxnerova, Z., Imrich, J., Kristian, P., Tomascikova, J., … Antalik, M. (2008). Acridine derivatives inhibit lysozyme aggregation. European Biophysics Journal, 37, 1261–1270.10.1007/s00249-008-0313-0
   PubMed Web of Science ®Google Scholar
• Geddes, C. D. (2001). Optical halide sensing using fluorescence quenching: Theory, simulations and applications – A review. Measurement Science and Technology, 12, R53–R88.10.1088/0957-0233/12/9/201
   Web of Science ®Google Scholar
• Ghobeh, M., Ahmadian, S., Meratan, A. A., Ebrahim-Habibi, A., Ghasemi, A., Shafizadeh, M., & Nemat-Gorgani, M. (2014). Interaction of A beta(25–35) fibrillation products with mitochondria: Effect of small-molecule natural products. Biopolymers, 102, 473–486.10.1002/bip.v102.6
   PubMed Web of Science ®Google Scholar
• Guijarro, J. I., Sunde, M., Jones, J. A., Campbell, I. D., & Dobson, C. M. (1998). Amyloid fibril formation by an SH3 domain. Proceedings of the National Academy of Sciences of the United States of America, 95, 4224–4228.10.1073/pnas.95.8.4224
   PubMed Web of Science ®Google Scholar
• Haldar, S., Mitra, S., & Chattopadhyay, K. (2010). Role of protein stabilizers on the conformation of the unfolded state of cytochrome c and its early folding kinetics investigation at single molecular resolution. Journal of Biological Chemistry, 285, 25314–25323.10.1074/jbc.M110.116673
   PubMed Web of Science ®Google Scholar
• How, S. C., Yang, S. M., Hsin, A., Tseng, C. P., Hsueh, S. S., Lin, M. S., … Wang, S. S. S. (2016). Examining the inhibitory potency of food additive fast green FCF against amyloid fibrillogenesis under acidic conditions. Food & Function, 7, 4898–4907.10.1039/C6FO00792A
   PubMed Web of Science ®Google Scholar
• Howlett, D. R., Perry, A. E., Godfrey, F., Swatton, J. E., Jennings, K. H., Spitzfaden, C., … Markwell, R. E. (1999). Inhibition of fibril formation in beta-amyloid peptide by a novel series of benzofurans. Biochemical Journal, 340, 283–289.10.1042/bj3400283
   PubMed Web of Science ®Google Scholar
• Kegel, K. B., Schewkunow, V., Sapp, E., Masso, N., Wanker, E. E., DiFiglia, M., & Goldmann, W. H. (2009). Polyglutamine expansion in huntingtin increases its insertion into lipid bilayers. Biochemical and Biophysical Research Communications, 387, 472–475.10.1016/j.bbrc.2009.07.039
   PubMed Web of Science ®Google Scholar
• Krebs, M. R. H., Wilkins, D. K., Chung, E. W., Pitkeathly, M. C., Chamberlain, A. K., Zurdo, J., … Dobson, C. M. (2000). Formation and seeding of amyloid fibrils from wild-type hen lysozyme and a peptide fragment from the beta-domain. Journal of Molecular Biology, 300, 541–549.10.1006/jmbi.2000.3862
   PubMed Web of Science ®Google Scholar
• Kuo, C. T., Chen, Y. L., Hsu, W. T., How, S. C., Cheng, Y. H., Hsueh, S. S., … Wang, S. S. S. (2017). Investigating the effects of erythrosine B on amyloid fibril formation derived from lysozyme. International Journal of Biological Macromolecules, 98, 159–168.10.1016/j.ijbiomac.2017.01.110
   PubMed Web of Science ®Google Scholar
• Lee, D., Lee, E. K., Lee, J. H., Chang, C. S., & Paik, S. R. (2001). Self-oligomerization and protein aggregation of alpha-synuclein in the presence of coomassie brilliant blue. European Journal of Biochemistry, 268, 295–301.10.1046/j.1432-1033.2001.01877.x
   PubMedGoogle Scholar
• Liu, K. N., Lai, C. M., Lee, Y. T., Wang, S. N., Chen, R. P. Y., Jan, J. S., … Wang, S. S. S. (2012). Curcumin’s pre-incubation temperature affects its inhibitory potency toward amyloid fibrillation and fibril-induced cytotoxicity of lysozyme. Biochimica et Biophysica Acta – General Subjects, 1820, 1774–1786.10.1016/j.bbagen.2012.07.012
   PubMed Web of Science ®Google Scholar
• Malisauskas, R., Botyriute, A., Cannon, J. G., & Smirnovas, V. (2015). Flavone derivatives as inhibitors of insulin amyloid-like fibril formation. PLoS ONE, 10, e0121231.
   PubMed Web of Science ®Google Scholar
• Mishra, R., Sorgjerd, K., Nystrom, S., Nordigarden, A., Yu, Y. C., & Hammarstrom, P. (2007). Lysozyme amyloidogenesis is accelerated by specific nicking and fragmentation but decelerated by intact protein binding and conversion. Journal of Molecular Biology, 366, 1029–1044.10.1016/j.jmb.2006.11.084
   PubMed Web of Science ®Google Scholar
• Morara, A. D., & McCarley, R. L. (2006). Encapsulation of neutral guests by tri(ethylene oxide)-pyrrole-terminated dendrimer hosts in water. Organic Letters, 8, 1999–2002.10.1021/ol060288i
   PubMed Web of Science ®Google Scholar
• Necula, M., Breydo, L., Milton, S., Kayed, R., van der Veer, W. E., Tone, P., & Glabe, C. G. (2007). Methylene blue inhibits amyloid Abeta oligomerization by promoting fibrillization. Biochemistry, 46, 8850–8860.10.1021/bi700411 k
   PubMed Web of Science ®Google Scholar
• Nielsen, L., Khurana, R., Coats, A., Frokjaer, S., Brange, J., Vyas, S., … Fink, A. L. (2001). Effect of environmental factors on the kinetics of insulin fibril formation: Elucidation of the molecular mechanism. Biochemistry, 40, 6036–6046.10.1021/bi002555c
   PubMed Web of Science ®Google Scholar
• Park, K. W., Kim, H. S., Cheon, S. M., Cha, J. K., Kim, S. H., & Kim, J. W. (2011). Dementia with lewy bodies vs. alzheimer’s disease and Parkinson’s disease dementia: A comparison of cognitive profiles. Journal of Clinical Neurology, 7, 19–24.10.3988/jcn.2011.7.1.19
   PubMed Web of Science ®Google Scholar
• Pepys, M. B., Hawkins, P. N., Booth, D. R., Vigushin, D. M., Tennent, G. A., Soutar, A. K., … Hsuan, J. J. (1993). Human lysozyme gene mutations cause hereditary systemic amyloidosis. Nature, 362, 553–557.10.1038/362553a0
   PubMed Web of Science ®Google Scholar
• Porat, Y., Abramowitz, A., & Gazit, E. (2006). Inhibition of amyloid fibril formation by polyphenols: Structural similarity and aromatic interactions as a common inhibition mechanism. Chemical Biology & Drug Design, 67, 27–37.10.1111/jpp.2006.67.issue-1
   PubMed Web of Science ®Google Scholar
• Rahmelow, K., & Hubner, W. (1996). Secondary structure determination of proteins in aqueous solution by infrared spectroscopy: A comparison of multivariate data analysis methods. Analytical Biochemistry, 241, 5–13.10.1006/abio.1996.0369
   PubMed Web of Science ®Google Scholar
• Ramos, C. H. I., & Ferreira, S. T. (2005). Protein folding, misfolding and aggregation: Evolving concepts and conformational diseases. Protein and Peptide Letters, 12, 213–222.10.2174/0929866053587156
   PubMed Web of Science ®Google Scholar
• Sharp, J. S., Forrest, J. A., & Jones, R. A. L. (2002). Surface denaturation and amyloid fibril formation of Insulin at model lipid−water interfaces. Biochemistry, 41, 15810–15819.10.1021/bi020525z
   PubMed Web of Science ®Google Scholar
• Siposova, K., Kozar, T., & Musatov, A. (2017). Interaction of nonionic detergents with the specific sites of lysozyme amyloidogenic region – Inhibition of amyloid fibrillization. Colloids and Surfaces B-Biointerfaces, 150, 445–455.10.1016/j.colsurfb.2016.11.010
   PubMed Web of Science ®Google Scholar
• Stefani, M., & Rigacci, S. (2013). Protein folding and aggregation into amyloid: The interference by natural phenolic compounds. International Journal of Molecular Sciences, 14, 12411–12457.10.3390/ijms140612411
   PubMed Web of Science ®Google Scholar
• Stevens, A., & Augusteyn, R. C. (1997). Binding of 1-anilinonaphthalene-8-sulfonic acid to alpha-crystallin. European Journal of Biochemistry, 243, 792–797.10.1111/ejb.1997.243.issue-3
   PubMedGoogle Scholar
• Thompson, A. J., & Barrow, C. J. (2002). Protein conformational misfolding and amyloid formation: Characteristics of a new class of disorders that include Alzheimer’s and prion diseases. Current Medicinal Chemistry, 9, 1751–1762.10.2174/0929867023369123
   PubMed Web of Science ®Google Scholar
• Uversky, V. N., & Fink, A. L. (2004). Conformational constraints for amyloid fibrillation: The importance of being unfolded. Biochimica Et Biophysica Acta – Proteins and Proteomics, 1698, 131–153.10.1016/j.bbapap.2003.12.008
   PubMed Web of Science ®Google Scholar
• Vaney, M. C., Maignan, S., Ries-Kautt, M., & Ducriux, A. (1996). High-resolution structure (1.33 A) of a HEW lysozyme tetragonal crystal grown in the APCF apparatus. Data and structural comparison with a crystal grown under microgravity from SpaceHab-01 mission. Acta Crystallographica Section D Biological Crystallography, 52, 505–517.10.1107/S090744499501674X
   PubMedGoogle Scholar
• Vuong, Q. V., Siposova, K., Nguyen, T. T., Antosova, A., Balogova, L., Drajna, L., … Gazova, Z. (2013). Binding of glyco-acridine derivatives to lysozyme leads to inhibition of amyloid fibrillization. Biomacromolecules, 14, 1035–1043.10.1021/bm301891q
   PubMed Web of Science ®Google Scholar
• Walker, L. C., & LeVine, H. (2000). Protein conformational diseases: The case for new semantic currency. Neurobiology of Aging, 21, 567–567.10.1016/S0197-4580(00)00156-1
   PubMed Web of Science ®Google Scholar
• Wang, S. S., Liu, K. N., & Wang, B. W. (2010). Effects of dithiothreitol on the amyloid fibrillogenesis of hen egg-white lysozyme. European Biophysics Journal, 39, 1229–1242.10.1007/s00249-010-0576-0
   PubMed Web of Science ®Google Scholar
• Wang, S. S., Liu, K. N., Wu, C. H., & Lai, J. K. (2009). Investigating the influences of redox buffer compositions on the amyloid fibrillogenesis of hen egg-white lysozyme. Biochimica et Biophysica Acta (BBA) – Proteins and Proteomics, 1794, 1663–1672.10.1016/j.bbapap.2009.07.017
   PubMed Web of Science ®Google Scholar
• Wang, W. (2005). Protein aggregation and its inhibition in biopharmaceutics. International Journal of Pharmaceutics, 289, 1–30.10.1016/j.ijpharm.2004.11.014
   PubMed Web of Science ®Google Scholar
• Wang, S. S. S., & Good, T. A. (2005). An overview of Alzheimer’s disease. Journal of the Chinese Institute of Chemical Engineers, 36, 533–559.
   Google Scholar
• Wang, S. S. S., Liu, K. N., & Lee, W. H. (2009). Effect of curcumin on the amyloid fibrillogenesis of hen egg-white lysozyme. Biophysical Chemistry, 144, 78–87.10.1016/j.bpc.2009.06.010
   PubMed Web of Science ®Google Scholar
• Wang, S. S. S., Liu, K. N., & Lu, Y. C. (2009). Amyloid fibrillation of hen egg-white lysozyme is inhibited by TCEP. Biochemical and Biophysical Research Communications, 381, 639–642.10.1016/j.bbrc.2009.02.103
   PubMed Web of Science ®Google Scholar
• Wang, S. S., Wu, J. W., Yamamoto, S., & Liu, H. S. (2008). Diseases of protein aggregation and the hunt for potential pharmacological agents. Biotechnology Journal, 3, 165–192.10.1002/(ISSN)1860-7314
   PubMedGoogle Scholar
• Wang, W., Nema, S., & Teagarden, D. (2010). Protein aggregation – Pathways and influencing factors. International Journal of Pharmaceutics, 390, 89–99.10.1016/j.ijpharm.2010.02.025
   PubMed Web of Science ®Google Scholar
• Wawer, J., Krakowiak, J., Szocinski, M., Lustig, Z., Olszewski, M., & Szostak, K. (2014). Inhibition of amyloid fibril formation of hen egg white lysozyme by trimethylamine N-oxide at low pH. International Journal of Biological Macromolecules, 70, 214–221.10.1016/j.ijbiomac.2014.06.057
   PubMed Web of Science ®Google Scholar
• Wen, W. S., Lai, J. K., Lin, Y. J., Lai, C. M., Huang, Y. C., Wang, S. S. S., & Jan, J. S. (2012). Effects of copolypeptides on amyloid fibrillation of hen egg-white lysozyme. Biopolymers, 97, 107–116.10.1002/bip.21707
   PubMed Web of Science ®Google Scholar
• Wi, S., Pancoska, P., & Keiderling, T. A. (1998). Predictions of protein secondary structures using factor analysis on Fourier transform infrared spectra: Effect of Fourier self-deconvolution of the amide I and amide II bands. Biospectroscopy, 4, 93–106.10.1002/(ISSN)1520-6343
   PubMedGoogle Scholar
• Wong, H. E., Qi, W., Choi, H. M., Fernandez, E., & Kwon, I. (2011). A safe, blood-brain barrier permeable triphenylmethane dye inhibits annyloid-beta neurotoxicity by generating nontoxic aggregates. ACS Chemical Neuroscience, 2, 645–657.10.1021/cn200056g
   PubMed Web of Science ®Google Scholar
• Yon, J. M. (2002). Protein folding in the post-genomic era. Journal of Cellular and Molecular Medicine, 6, 307–327.10.1111/jcmm.2002.6.issue-3
   PubMed Web of Science ®Google Scholar